Crossmark

Single-Agent Capecitabine: A Safe and Effective Option in Refractory Gestational Trophoblastic Neoplasia

Published Online: 2024-09-11

Published Print: 2024-12

Authors

Saj, Fen

Durairaj, Jayalakshmi

Ganesan, Prasanth https://orcid.org/0000-0003-2762-6591
License Information

Text and Data Mining valid from 2024-09-11

Version of Record valid from 2024-09-11
More Information

Article History

Received: 30 April 2024

Revised: 19 August 2024

Accepted: 24 August 2024

First Online: 11 September 2024

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current